Pfizer To Apply For Emergency Use For Its Covid-19 Vaccine
Pfizer announced it will submit an application to the Food and Drug Administration Friday for an emergency use authorization for its experimental Covid-19 vaccine. Dr. Scott Gottlieb joins Morning Joe to discuss. Aired on 11/20/2020.
CNBC.com's MacKenzie Sigalos has the day's top business news headlines. Pfizer submitted its Covid-19 vaccine to the FDA for emergency authorization today, kicking off the first step of the approval and deployment process. But CNBC's Bertha Coombs explains how, at the same time, the combination of rising infection and Thanksgiving travel prep is putting a strain on some clinics that offer tests for the virus. Plus, the "After Hours" team dives into the rave reviews for Apple's new M1 chips.
00:00 -- Intro
0:40 -- Stocks close the week mixed
2:26 -- Covid-19 testing bottlenecks
4:13 -- CNBC Soundcheck
5:45 -- Apple's M1 Debut
9:37 -- Numbers Round Moderna says it will today ask for approval for its COVID-19 vaccine in Europe and the US Moderna Inc. says it will ask U.S. and European regulators to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection. (Nov. 30) Pfizer and BioNTech say they've won permission for emergency use of their COVID-19 vaccine in the United Kingdom. British media reports suggest vaccinations for medical workers could start as early as next week.